Stock research
NMAD NOMAD Power Solutions, Inc.
Healthcare • Biotechnology
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in...…
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Boca Raton, FL.
ALL change
-32.63%
Range high
$8.04
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in NMAD?
Price
Showing ALL history. Source: FMP historical price full.
- Prev Close
- $4.17
- Day High
- $4.70
- Day Low
- $4.15
- 52w High
- $8.38
- 52w Low
- $2.36
- Volume
- 763,632
- Avg Volume
- Beta
- 1.2505351
* TTM/most recent where available
Company
- Ticker
- NMAD
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Geordan G. Pursglove
- Employees
- 3
- Website
- nomadpower.com
Key Metrics
- Market Cap
- 55.4M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price